Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02970305
What this trial is testing

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

Who this might be right for
Schizophrenia
ACADIA Pharmaceuticals Inc. 403
Large-scale testing (Phase 3)Study completedNCT00210769
What this trial is testing

The Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203
Large-scale testing (Phase 3)Study completedNCT00128505
What this trial is testing

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 104
Post-approval studies (Phase 4)Study completedNCT02435654
What this trial is testing

5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

Who this might be right for
Early-onset Schizophrenia
Kunming Medical University 128
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Early research (Phase 1)Study completedNCT01959594
What this trial is testing

Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers

Who this might be right for
Healthy
Pfizer 40
Post-approval studies (Phase 4)Study completedNCT01015586
What this trial is testing

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

Who this might be right for
Alcohol DependenceBipolar DisorderDepression+2 more
Medical University of South Carolina 43
Not applicableStudy completedNCT02782442
What this trial is testing

Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)

Who this might be right for
TreatmentActive ControlSchizophrenia+7 more
University of Minnesota 109
Early research (Phase 1)Study completedNCT02567370
What this trial is testing

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Who this might be right for
Schizophrenia or Schizoaffective Disorder
Amgen 70
Testing effectiveness (Phase 2)WithdrawnNCT02197286
What this trial is testing

Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

Who this might be right for
SchizophreniaSchizoaffective Disorder
NYU Langone Health
Not applicableStudy completedNCT02451670
What this trial is testing

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

Who this might be right for
Chronic DiseaseMental DisorderHealth Behavior+2 more
HealthPartners Institute 10,347
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Large-scale testing (Phase 3)Study completedNCT00237939
What this trial is testing

Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,200
Testing effectiveness (Phase 2)Ended earlyNCT03868839
What this trial is testing

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective DisorderTreatment-resistant Schizophrenia
Xiaoduo Fan 6
Testing effectiveness (Phase 2)Study completedNCT02953639
What this trial is testing

Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

Who this might be right for
Schizophrenia
Hoffmann-La Roche 214
Not applicableUnknownNCT04051775
What this trial is testing

Non-Pharmacological Treatment of Psychosis

Who this might be right for
Psychosis; Schizophrenia-Like
Haukeland University Hospital 50
Not applicableStudy completedNCT02566057
What this trial is testing

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 36
Not applicableUnknownNCT04332601
What this trial is testing

Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia

Who this might be right for
Schizophrenia
University Hospital, Montpellier 200
Early research (Phase 1)Study completedNCT02228395
What this trial is testing

Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers

Who this might be right for
Healthy
Biogen 12
Not applicableStudy completedNCT02660775
What this trial is testing

Social Cognitive Assessment in Autism and Schizophrenia

Who this might be right for
Schizophrenia
Hôpital le Vinatier 440
Next Page